ArticlePLoS biology2026

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

Dario Pasquale Anobile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.